Twin Tree Management, LP Incyte Corp Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

A detailed history of Twin Tree Management, LP transactions in Incyte Corp stock. As of the latest transaction made, Twin Tree Management, LP holds 1,600 shares of INCY stock, worth $116,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Previous 1,600 -0.0%

Holding current value

$116,144

Previous $96,000 9.38%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$56.55 - $66.59 $4.16 Million - $4.9 Million	-73,531 Reduced 64.6%	40,287 $2.3 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $5.94 Million - $7.31 Million	113,818 New	113,818 $7.15 Million
Q1 2023 May 10, 2023	SELL	$70.23 - $86.01 $780,676 - $956,087	-11,116 Reduced 76.23%	3,466 $250,000
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $131,941 - $165,192	-1,964 Reduced 11.87%	14,582 $1.17 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $1.07 Million - $1.34 Million	16,161 Added 4197.66%	16,546 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $619,643 - $778,814	-9,363 Reduced 96.05%	385 $29,000
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $643,562 - $777,013	9,748 New	9,748 $774,000
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $1.88 Million - $2.31 Million	-27,446 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $1.45 Million - $1.59 Million	18,214 Added 197.29%	27,446 $2.31 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $1.58 Million - $2.09 Million	-20,755 Reduced 69.21%	9,232 $750,000
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $1.82 Million - $2.21 Million	22,598 Added 305.83%	29,987 $2.61 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $2.31 Million - $2.98 Million	-27,149 Reduced 78.61%	7,389 $663,000
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $2.31 Million - $3.4 Million	31,194 Added 932.83%	34,538 $3.59 Million
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $1.63 Million - $2.22 Million	-25,823 Reduced 88.53%	3,344 $245,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.59 Million - $2.08 Million	21,772 Added 294.42%	29,167 $2.55 Million
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $671,910 - $798,320	-9,227 Reduced 55.51%	7,395 $549,000
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $825,262 - $995,657	-11,225 Reduced 40.31%	16,622 $1.41 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $53,771 - $74,591	846 Added 3.13%	27,847 $2.4 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $756,229 - $904,114	-12,927 Reduced 32.38%	27,001 $1.72 Million
Q3 2018 Nov 09, 2018	BUY	$61.75 - $74.23 $39,643 - $47,655	642 Added 1.63%	39,928 $2.76 Million
Q2 2018 Aug 08, 2018	BUY	$60.85 - $83.98 $2.39 Million - $3.3 Million	39,286 New	39,286 $2.63 Million
Q1 2018 May 09, 2018	SELL	$83.06 - $100.98 $124,340 - $151,167	-1,497 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $67,363 - $83,952	720 Added 92.66%	1,497 $142,000
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $84,809 - $107,435	777	777 $91,000

Others Institutions Holding INCY

# of Institutions

653

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Incyte Corp Transaction History